New Delhi, May 27 -- Widely regarded as one of the greatest modern scientists, geneticist and Nobel laureate Sir Paul Nurse spoke to HT about India's research landscape, impact of budget cuts on the future of research, and his work that led to him winning the Nobel Prize in Physiology or Medicine in 2001. Edited excerpts: What I work on is cells. We're all made of billions of cells. I work on the process called cell cycle by which a cell reproduces itself from one to two. That requires a series of events: Events that particularly lead to the doubling of the DNA and the segregation/separation into two newly divided cells. What controls that overall process, what goes through all those events in the right order, and the impact that led to the Nobel Prize was the discovery that it's a very simple system: There's a particular enzyme called cyclin-dependent kinases, which increases as you go through the cycle and fires off different events at different levels. And then when it gets to the end of the cycle, it's destroyed and then it goes through it again. I'm not actually a cancer specialist, but it is a bit strange. The usual answer, which I'm not sure is completely correct, is to say we get older, we survive other diseases -- particularly infectious diseases -- which we've managed to control. And that has meant that there's a greater incidence of cancer. The second thing is that we are better at diagnosing cancer. So, when people have it, we know that they've had it. Having said that, there's something else going on that I don't think we fully understand such as environmental factors, but I am not sure how much of that its responsible. It is going to be an incredibly useful tool for routine activities such as examining images to look for telltale signs that something may happen. If you see a blob somewhere and six months later that leads to cancer, then you don't actually need to know what the blob means or how it develops. That's enough to say we should be paying attention to it. It also isn't only to do with imaging, but it's to do with everything. Maybe if you get routine tests, there might be a combination of certain factors that no doctor would take any notice at all. But, if we have the data -- which AI can interrogate then you might understand that there's a certain combination of factors that none of which are attracting attention individually, but together might mean that something will happen. But, will it lead to new treatment? That's a more complicated business. You move in a somewhat different direction, which is to do with whether AI will help what we call discovery research about how to understand what is going on in a process like cancer. Now, the answer is yes, but maybe not quite as dramatic as what I just said about diagnosis. The Indian situation in science is at a very exciting turn. I've been coming to India for 40 years and we are seeing a transformation in the capability of what Indian science can produce. Indian science, mathematics particularly, and the computing link to it has always been the front-runner in the world. We'll never forget where zero was invented a thousand years ago....